106 related articles for article (PubMed ID: 7557352)
21. Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease.
Gomez-Isla T; West HL; Rebeck GW; Harr SD; Growdon JH; Locascio JJ; Perls TT; Lipsitz LA; Hyman BT
Ann Neurol; 1996 Jan; 39(1):62-70. PubMed ID: 8572669
[TBL] [Abstract][Full Text] [Related]
22. Incidence of dementia in very elderly individuals: a clinical, neuropathological and molecular genetic study.
Polvikoski T; Sulkava R; Rastas S; Sutela A; Niinistö L; Notkola IL; Verkkoniemi A; Viramo P; Juva K; Haltia M
Neuroepidemiology; 2006; 26(2):76-82. PubMed ID: 16352910
[TBL] [Abstract][Full Text] [Related]
23. Apolipoprotein E phenotypes, dementia and mortality in a prospective population sample.
Tilvis RS; Strandberg TE; Juva K
J Am Geriatr Soc; 1998 Jun; 46(6):712-5. PubMed ID: 9625186
[TBL] [Abstract][Full Text] [Related]
24. Odor identification impairment in carriers of ApoE-varepsilon4 is independent of clinical dementia.
Olofsson JK; Nordin S; Wiens S; Hedner M; Nilsson LG; Larsson M
Neurobiol Aging; 2010 Apr; 31(4):567-77. PubMed ID: 18619712
[TBL] [Abstract][Full Text] [Related]
25. Apolipoprotein E allele epsilon 4, dementia, and cognitive decline in a population sample.
Henderson AS; Easteal S; Jorm AF; Mackinnon AJ; Korten AE; Christensen H; Croft L; Jacomb PA
Lancet; 1995 Nov; 346(8987):1387-90. PubMed ID: 7475820
[TBL] [Abstract][Full Text] [Related]
26. Apolipoprotein E genotype in the prediction of cognitive decline and dementia in a prospectively studied elderly population.
Brayne C; Harrington CR; Wischik CM; Huppert FA; Chi LY; Xuereb JH; O'Connor DW; Paykel ES
Dementia; 1996; 7(3):169-74. PubMed ID: 8740632
[TBL] [Abstract][Full Text] [Related]
27. APOE epsilon 4 allele in Alzheimer's and non-Alzheimer's dementias.
Itabashi S; Arai H; Higuchi S; Sasaki H; Trojanowska JQ
Lancet; 1996 Oct; 348(9032):960-1. PubMed ID: 8843828
[No Abstract] [Full Text] [Related]
28. Apolipoprotein E-epsilon 4 allele and Alzheimer's disease.
Ben-Shlomo Y; Lewis G; McKeigue PM
Lancet; 1993 Nov; 342(8882):1310. PubMed ID: 7901626
[No Abstract] [Full Text] [Related]
29. Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population based study.
Kuusisto J; Koivisto K; Kervinen K; Mykkänen L; Helkala EL; Vanhanen M; Hänninen T; Pyörälä K; Kesäniemi YA; Riekkinen P
BMJ; 1994 Sep; 309(6955):636-8. PubMed ID: 8086986
[TBL] [Abstract][Full Text] [Related]
30. Risk of dementia in parents of probands with and without the apolipoprotein E4 allele. The EVA study.
Danet S; Brousseau T; Richard F; Amouyel P; Berr C
J Epidemiol Community Health; 1999 Jul; 53(7):393-8. PubMed ID: 10492731
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of dementia and distribution of ApoE alleles in Japanese centenarians: an almost-complete survey in Yamanashi Prefecture, Japan.
Asada T; Yamagata Z; Kinoshita T; Kinoshita A; Kariya T; Asaka A; Kakuma T
J Am Geriatr Soc; 1996 Feb; 44(2):151-5. PubMed ID: 8576504
[TBL] [Abstract][Full Text] [Related]
32. Apolipoprotein epsilon-4 allele and the two-year progression of cognitive function in Chinese subjects with late-onset Alzheimer's disease.
Lam LC; Tang NL; Ma SL; Lui VW; Chan AS; Leung PY; Chiu HF
Am J Alzheimers Dis Other Demen; 2006; 21(2):92-9. PubMed ID: 16634464
[TBL] [Abstract][Full Text] [Related]
33. Attenuation of apolipoprotein E Epsilon4 allele gene dose in late age.
Corder EH; Basun H; Lannfelt L; Viitanen M; Winblad B
Lancet; 1996 Feb; 347(9000):542. PubMed ID: 8596288
[No Abstract] [Full Text] [Related]
34. Olfactory function in people with genetic risk of dementia.
Salerno-Kennedy R; Cusack S; Cashman KD
Ir J Med Sci; 2005; 174(4):46-50. PubMed ID: 16445161
[TBL] [Abstract][Full Text] [Related]
35. Apolipoprotein E in patients with dementia of the Alzheimer type and vascular dementia.
Isoe K; Urakami K; Sato K; Takahashi K
Acta Neurol Scand; 1996; 93(2-3):133-7. PubMed ID: 8741132
[TBL] [Abstract][Full Text] [Related]
36. Effects of apolipoprotein E phenotypes on the neuropsychological functions of community-dwelling elderly individuals without dementia.
Chey J; Kim JW; Cho HY
Neurosci Lett; 2000 Aug; 289(3):230-4. PubMed ID: 10961672
[TBL] [Abstract][Full Text] [Related]
37. Apolipoprotein E genotyping in Alzheimer's disease.
McKeith IG; Morris CM
Lancet; 1996 Jun; 347(9017):1775. PubMed ID: 8656943
[No Abstract] [Full Text] [Related]
38. Apolipoprotein E polymorphism and low density lipoprotein (LDL) oxidation in patients with dementia.
Wehr H; Bednarska-Makaruk M; Graban A; Kunicki PK; Lojkowska W; Rodo M; Ryglewicz D
Folia Neuropathol; 2003; 41(2):65-8. PubMed ID: 12899198
[TBL] [Abstract][Full Text] [Related]
39. APOE genotyping in differential diagnosis of Alzheimer's disease.
Slooter AJ; Breteler MB; Ott A; Van Broeckhoven C; van Duijn CM
Lancet; 1996 Aug; 348(9023):334. PubMed ID: 8709703
[No Abstract] [Full Text] [Related]
40. Epidemiologic and genetic studies of dementia of the alzheimer type in japan.
Urakami K; Adachi Y; Wakutani Y; Isoe K; Ji Y; Takahashi K; Nakashima K
Dement Geriatr Cogn Disord; 1998; 9(5):294-8. PubMed ID: 9701681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
